Affiliations
AffiliationItem in Clipboard
Correlation between computed tomographic findings, bronchioloalveolar carcinoma component, and biologic behavior of small-sized lung adenocarcinomasMorihito Okada et al. J Thorac Cardiovasc Surg. 2004 Mar.
Free article . 2004 Mar;127(3):857-61. doi: 10.1016/j.jtcvs.2003.08.048. AffiliationItem in Clipboard
AbstractObjective: Differentiation of bronchioloalveolar carcinoma from other subtypes of lung adenocarcinomas is important in the preoperative assessment of patients. We examined the biologic aggressiveness of small-sized adenocarcinomas according to the pathologically defined bronchioloalveolar carcinoma degree and its correlation with computed tomography findings. In addition, we attempted to predict which patients were suitable for a lesser resection.
Methods: Of 424 consecutive patients who underwent operation for primary lung cancer in the last 3 years, 114 with a histopathologically proven adenocarcinoma 3 cm or less in diameter underwent complete removal of the primary tumor. We examined the characteristics of patients classified into 3 groups based on the proportion of the bronchioloalveolar carcinoma component: 0% to 20% (n = 40), 21% to 50% (n = 38), and 51% to 100% (n = 36). We also investigated the correlation of the bronchioloalveolar carcinoma component with computed tomography findings such as ground-glass opacity (defined as a hazy increase on the lung window) and tumor shadow disappearance rate (defined as the ratio of the tumor area of the mediastinal window to that of the lung window).
Results: Male gender (P =.0001), advanced pathologic stage (P =.001), larger size of the tumor (P =.004), nodal involvement (P =.04), pleural invasion (P =.0003), lymphatic invasion (P =.002), and vascular invasion (P =.0002) were observed more often among patients with a smaller proportion of bronchioloalveolar carcinoma. A positive and significant correlation was found between the rate of bronchioloalveolar carcinoma component and ground-glass opacity (R(2) = 0.488, P <.0001) and tumor shadow disappearance rate (R(2) = 0.727, P <.0001). As an independent predictor of nodal status, tumor shadow disappearance rate (P =.015) and bronchioloalveolar carcinoma component (P =.015), as well as tumor size, were significantly valuable, although ground-glass opacity proportion (P =.086) was marginally informative.
Conclusions: Small-sized adenocarcinomas with a greater ratio of bronchioloalveolar carcinoma component showed less aggressive behavior. Both tumor shadow disappearance rate and ground-glass opacity ratios, which are obtained preoperatively, were well associated with bronchioloalveolar carcinoma ratios, which are determined postoperatively. Furthermore, tumor shadow disappearance rate had a stronger impact as a predictor of bronchioloalveolar carcinoma component. Preoperative assessment of tumor shadow disappearance rate may be useful to identify patients requiring a less extensive pulmonary resection.
Similar articlesOkada M, Tauchi S, Iwanaga K, Mimura T, Kitamura Y, Watanabe H, Adachi S, Sakuma T, Ohbayashi C. Okada M, et al. J Thorac Cardiovasc Surg. 2007 Jun;133(6):1448-54. doi: 10.1016/j.jtcvs.2007.02.023. J Thorac Cardiovasc Surg. 2007. PMID: 17532938
Okada M, Nakayama H, Okumura S, Daisaki H, Adachi S, Yoshimura M, Miyata Y. Okada M, et al. J Thorac Cardiovasc Surg. 2011 Jun;141(6):1384-91. doi: 10.1016/j.jtcvs.2011.02.007. Epub 2011 Mar 25. J Thorac Cardiovasc Surg. 2011. PMID: 21440264
Matsuguma H, Yokoi K, Anraku M, Kondo T, Kamiyama Y, Mori K, Tominaga K, Tsuura Y, Honjo S. Matsuguma H, et al. J Thorac Cardiovasc Surg. 2002 Aug;124(2):278-84. doi: 10.1067/mtc.2002.122298. J Thorac Cardiovasc Surg. 2002. PMID: 12167787
Lee HY, Lee KS. Lee HY, et al. J Thorac Imaging. 2011 May;26(2):106-18. doi: 10.1097/RTI.0b013e3181fbaa64. J Thorac Imaging. 2011. PMID: 21508733 Review.
Fukui T, Sakakura N, Mori S, Hatooka S, Shinoda M, Yatabe Y, Mitsudomi T. Fukui T, et al. J Thorac Oncol. 2007 Jun;2(6):546-52. doi: 10.1097/JTO.0b013e318060d30d. J Thorac Oncol. 2007. PMID: 17545852 Review.
Tamura M, Oda M, Matsumoto I, Shimizu Y, Waseda R, Watanabe G. Tamura M, et al. World J Surg. 2011 Sep;35(9):2010-5. doi: 10.1007/s00268-011-1145-0. World J Surg. 2011. PMID: 21633846
Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D. Travis WD, et al. J Thorac Oncol. 2011 Feb;6(2):244-85. doi: 10.1097/JTO.0b013e318206a221. J Thorac Oncol. 2011. PMID: 21252716 Free PMC article. Review.
Nagashima T, Shimizu K, Ohtaki Y, Obayashi K, Kakegawa S, Nakazawa S, Kamiyoshihara M, Igai H, Takeyoshi I. Nagashima T, et al. Gen Thorac Cardiovasc Surg. 2015 Jun;63(6):354-60. doi: 10.1007/s11748-015-0531-1. Epub 2015 Feb 28. Gen Thorac Cardiovasc Surg. 2015. PMID: 25724170 Free PMC article.
Sakao Y, Kuroda H, Mun M, Uehara H, Motoi N, Ishikawa Y, Nakagawa K, Okumura S. Sakao Y, et al. PLoS One. 2014 Nov 3;9(11):e110305. doi: 10.1371/journal.pone.0110305. eCollection 2014. PLoS One. 2014. PMID: 25365326 Free PMC article.
Zhong X, Huang Y, Yang M, Jia L, Wu Y, Zhu Y, Li H, Chen Q. Zhong X, et al. Ann Transl Med. 2022 Jan;10(2):46. doi: 10.21037/atm-21-6282. Ann Transl Med. 2022. PMID: 35282123 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3